Inside Kodiak Sciences: CFO’s $1.04 Share Buy Signals Optimistic Pipeline Growth
Insightful: Kodiak Sciences CFO buys shares at $1.04—signals insider confidence in retinal‑therapeutics pipeline and upcoming regulatory milestones.
4 minutes to read
Kodiak Sciences Inc
Insider Confidence: Kodiak CFO Buys 30,000 Shares at 1.04 – A Bullish Signal for Investors
Discover why Kodiak Sciences CFO John Borgeson bought $1.04 shares amid sales, signaling confidence in the biotech’s clinical pipeline and long‑term upside.
3 minutes to read
Victor Perlroth Buys 300,000 Kodiak Shares, Boosting Confidence Ahead of FDA Zenkuda Submission
CEO Victor Perlroth’s $1.04 buy of 300k Kodiak Sciences shares underscores strong insider confidence amid soaring Phase III results and a looming FDA Zenkuda submission.
4 minutes to read